Sexual Health and Breast Cancer: Developing Appropriate Education for Women Going Through Treatment
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Madeline G Huey, MD
- Phone Number: 303-570-2611
- Email: madeline.huey@cuanschutz.edu
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Health
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Stage I-III invasive breast cancer within one month of initial multi-disciplinary clinic visit or surgical consultation
- Ability to complete survey material independently
- Able to read and speak English
- Willingness to comply with study material and procedures
Exclusion Criteria:
- Age < 18 years old
- Stage 0 or IV breast cancer
- Non-breast cancer diagnoses
- History of anti-hormonal therapy, chemotherapy, or radiotherapy not related to breast cancer
- Prior breast cancer diagnosis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Video website access
Participants will gain access to the educational video website in order to watch the series.
|
The intervention is a web-based educational video series that was developed using a patient-centered approach that discusses breast cancer treatment, sexual health side effects, and provides treatment and mitigation strategies for these side effects.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of the educational video series after six-months of access and use by breast cancer patients as measured by AIM instrument.
Time Frame: 6 months
|
The Acceptability of Intervention Measure (AIM) is a validated instrument used to measure the acceptability of an intervention.
Scores range from 0-5.
There is no score cut off, however higher scores indicate better outcomes (greater acceptability).
|
6 months
|
|
Appropriateness of the educational video series after six-months of access and use by breast cancer patients as measured by IAM instrument.
Time Frame: 6 months
|
The Intervention Appropriateness Measure (IAM) is a validated instrument used to measure the appropriateness of an intervention.
Scores range from 0-5.
There is no score cut off, however higher scores indicate better outcomes (greater appropriateness).
|
6 months
|
|
Determine the sustainability of the educational video series after six-months of access and use by breast cancer patients as measured by the FIM instrument.
Time Frame: 6 months
|
The Feasibility of Intervention Measure (FIM) is a validated instrument used to measure the feasibility, or sustainability, of an intervention.
Scores range from 0-5.
There is no score cut off, however higher scores indicate better outcomes (greater feasibility).
|
6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in sexual health and function at six-months, as measured by the PROMIS Sexual Function v2 Brief Profile (Female)
Time Frame: Baseline, 6 months
|
The Patient-Reported Outcomes Measurement Information System (PROMIS) Sexual Function v2 Brief Profile (Female) is a well-validated tool in oncology patients to assess sexual health.
Calibrated subdomain scores are expressed as T-scores (mean=50, standard deviation=10).
A T-score 50 corresponds to the mean response among cancer survivors used for previous item testing.
Higher scores indicate better outcomes within the domain.
We will assess the change at 6 months from baseline.
|
Baseline, 6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Sarah E Tevis, MD, University of Colorado, Denver
Publications and helpful links
General Publications
- Flynn KE, Lin L, Cyranowski JM, Reeve BB, Reese JB, Jeffery DD, Smith AW, Porter LS, Dombeck CB, Bruner DW, Keefe FJ, Weinfurt KP. Development of the NIH PROMIS (R) Sexual Function and Satisfaction measures in patients with cancer. J Sex Med. 2013 Feb;10 Suppl 1(0 1):43-52. doi: 10.1111/j.1743-6109.2012.02995.x.
- Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3.
- Tat S, Doan T, Yoo GJ, Levine EG. Qualitative Exploration of Sexual Health Among Diverse Breast Cancer Survivors. J Cancer Educ. 2018 Apr;33(2):477-484. doi: 10.1007/s13187-016-1090-6.
- Sporn NJ, Smith KB, Pirl WF, Lennes IT, Hyland KA, Park ER. Sexual health communication between cancer survivors and providers: how frequently does it occur and which providers are preferred? Psychooncology. 2015 Sep;24(9):1167-73. doi: 10.1002/pon.3736. Epub 2014 Dec 22.
- Stead ML, Brown JM, Fallowfield L, Selby P. Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues. Br J Cancer. 2003 Mar 10;88(5):666-71. doi: 10.1038/sj.bjc.6600799.
- Stabile C, Goldfarb S, Baser RE, Goldfrank DJ, Abu-Rustum NR, Barakat RR, Dickler MN, Carter J. Sexual health needs and educational intervention preferences for women with cancer. Breast Cancer Res Treat. 2017 Aug;165(1):77-84. doi: 10.1007/s10549-017-4305-6. Epub 2017 May 25.
- Huynh V, Vemuru S, Hampanda K, Pettigrew J, Fasano M, Coons HL, Rojas KE, Afghahi A, Ahrendt G, Kim S, Matlock DD, Tevis SE. No One-Size-Fits-All: Sexual Health Education Preferences in Patients with Breast Cancer. Ann Surg Oncol. 2022 Oct;29(10):6238-6251. doi: 10.1245/s10434-022-12126-7. Epub 2022 Aug 1.
- Higgins MG, Helmkamp L, Zimmaro LA, Leslie SE, Adams M, Vemuru S, Huynh VD, Baurle E, Bozzuto L, Rojas KE, Coons HL, Arkema A, Tevis S. Preliminary evaluation of the acceptability, appropriateness, and feasibility of an online sexual health educational video series for breast cancer patients. Support Care Cancer. 2026 Jan 26;34(2):130. doi: 10.1007/s00520-026-10381-y.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 23-1734.cc
- NCI-2023-10532 (Other Identifier: NCI CTRP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.